Patents by Inventor Dinender Singla

Dinender Singla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260325669
    Abstract: The present technology includes compositions comprising exosomes (i.e., “exosome compositions”) having one or more tumor-specific peptides (TSPs) (TSP-Exos) that guide the exosome composition to a desired target. The TSPs of the present technology may (i) bind to at least a portion of a cancer cell (e.g., a tumor cell) and/or a tumor microenvironment, or (ii) otherwise colocalize one or more exosomes with the cancer cell and/or the tumor microenvironment. The exosome compositions may penetrate the tumor microenvironment and are at least partially internalized by the cancer cell upon binding to at least a portion of the cancer cell by the TSP. For example, an exosome or a cargo thereof (e.g., an anticancer agent) is internalized by the cancer cell upon binding of the TSP.
    Type: Application
    Filed: March 27, 2026
    Publication date: October 22, 2026
    Inventors: Dinender Singla, Chandrakala Aluganti Narasimhulu
  • Publication number: 20140227219
    Abstract: In an aspect, the invention relates to compositions comprising BMP-7 and methods of using disclosed compositions. In an aspect, the invention relates to compositions for and methods of treating atherosclerosis. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Application
    Filed: February 8, 2014
    Publication date: August 14, 2014
    Applicant: University of Central Florida Research Foundation, Inc.
    Inventor: Dinender Singla
  • Publication number: 20130295064
    Abstract: Cardiac myocyte differentiation reported thus far is from iPS cells generated from mice and human fibroblasts. iPS cells from cardiac or ventricular specific cell types are generated herein having the potential to repair and regenerate infarcted myocardium. The cells were transduced with four sternness factors and reprogrammed them into iPS cells. These cardiac iPS cells were able to differentiate into beating cardiac myocytes, formed cardiac-specific structures, and positively stained for cardiac specific proteins. Transplanted cells also significantly inhibited apoptosis and fibrosis and improved cardiac function.
    Type: Application
    Filed: October 14, 2011
    Publication date: November 7, 2013
    Applicant: UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC.
    Inventor: Dinender Singla